IGI Logo

Zydus Lifesciences is currently trading at Rs. 1007.05, up by 30.25 points or 3.10% from its previous closing of Rs. 976.80 on the BSE.

The scrip opened at Rs. 986.60 and has touched a high and low of Rs. 1015.70 and Rs. 980.00 respectively. So far 44133 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1015.70 on 11-Mar-2024 and a 52 week low of Rs. 461.50 on 13-Mar-2023.

Last one week high and low of the scrip stood at Rs. 1015.70 and Rs. 920.50 respectively. The current market cap of the company is Rs. 102131.40 crore.

The promoters holding in the company stood at 74.98%, while Institutions and Non-Institutions held 18.03% and 6.99% respectively.

Zydus Lifesciences has received the Establishment Inspection Report (EIR) report from the USFDA for the inspection conducted at the API Ahmedabad facility. The company had earlier received Post Application Action Letter from the USFDA for the same inspection confirming that the inspected facility has been considered as ready to commercially manufacture and supply the API. This facility underwent an inspection from December 14 to 22, 2023 and has been classified as Voluntary Action Indicated (VAI).

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.